drugset
drugset / Trial / NCT00731250

A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model

NCT00731250 ↗

Phase 1 Completed 45 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study is designed to look at the affect of SB-705498 on rhinitis symptoms, as induced by capsaicin challenge

Timeline

Start
2008-07-22
Primary completion
2009-03-01
Completion
2009-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject SB-705498 Small molecule 400 mg —

Indications

rhinitis